Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc

EGRX

Get informed when a big investor buys or sells

+ Follow
Market Cap$7.57M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Eagle Pharmaceuticals IncEagle Pharmaceuticals Inc0.2-5%-0.5
$12.59

Current Fair Value

2636.5% upside

Undervalued by 2636.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$7.57 Million
Enterprise Value$122.44 Million
Dividend Yield$- (-)
Earnings per Share$2.76
Beta0.6
Outstanding Shares13,090,852

Return

Return on Equity4.74%ROE
Return on Assets2.95%
Return on Invested Capital9.52%

Valuation & Multiples

P/E Ratio0.21P/E Ratio
PEG-0.13PEG
Price to Sales0.02Price to Sales
Price to Book Ratio0.02Price to Book Ratio
Enterprise Value to Revenue0.48
Enterprise Value to EBIT4.04
Enterprise Value to Net Income10
Total Debt to Enterprise1.06
Debt to Equity0.52Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.09%0%
Total Invested$4,212▼ 51.28%
Investors Holding20%

ESG Score

No data

About Eagle Pharmaceuticals Inc

CEO: Scott Tarriff